Thromboxane synthetase inhibitors, thromboxane receptor antagonists, and aspirin in cardiovascular disease.
Thromboxane synthetase inhibitors, thromboxane receptor antagonists, and aspirin in cardiovascular disease. Ration Drug Ther. 1985 Jul; 19(7):1-7.